Skip to content

Anto Biosciences

YC F25 · Active · A Foundation Model for Microbial Communities.

Competitors

Adjacent

Also from F25 in AI

All of F25

Founders

  • Arvid E. GollwitzerFounder/CEO
  • David de GruijlFounder/CTO

About Anto Biosciences

Anto is building a foundation model for microbial communities, making the gut microbiome computable for the first time. We predict drug toxicity and efficacy across diverse populations and fix drugs so they work for everyone — solving the hidden root cause of most drug failures. Founded by Arvid (Broad Institute of MIT and Harvard; Nature-published researcher who pioneered quality-aware, goal-directed sparsification) and David (Harvard Medical School Gastroenterology, J&J), second-time founders who published the breakthrough at leading machine learning AI conferences and Nature.

YC batch
F25 · Fall 2025
Status, per YC
Active
Category
AI
Team size
4
Location
San Francisco, CA, USA
Founded
2025
Checked
35m ago

YC tags: Artificial Intelligence, Generative AI, Biotech, Genomics, Drug discovery

Anto Biosciences in F25: 146 companies, 89% AI

LinkedIn

Anto Biosciences: questions

Which YC batch was Anto Biosciences in?

Anto Biosciences was in Y Combinator's Fall 2025 batch (F25).

Is Anto Biosciences still active?

Y Combinator lists Anto Biosciences as active.

Who founded Anto Biosciences?

Anto Biosciences's founders, as listed on its YC page: Arvid E. Gollwitzer (Founder/CEO), David de Gruijl (Founder/CTO).

Where is Anto Biosciences based?

Anto Biosciences lists San Francisco, CA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.